Sentence examples for shortage of effective from inspiring English sources
A shortage of effective, recently trained teachers looks like the main reason for that.
Yet the apparent ease of that hijacking — and the shortage of effective protections against a recurrence — alarmed U.S. officials.
However, in part because of a chronic shortage of effective continuing professional development, the inconvenient truth remains that there are also thousands of terrible, terrible teachers.
Karen Benker Brooklyn, N.Y. Malcolm Gladwell looks to the National Football League and financial-services firms for answers to how we might solve our shortage of effective teachers ("Most Likely to Succeed," December 15th).
We are concerned about inadequate financing, the shortage of effective teachers, the misuse of standardized tests, the lumping together of all special-education students despite their wide differences, and the consequences for failure to meet yearly progress goals.
Malcolm Gladwell looks to the National Football League and financial-services firms for answers to how we might solve our shortage of effective teachers ("Most Likely to Succeed," December 15th).
However, empowering the utility of advanced IoT technology in PHS is still significantly challenging in the area considering many issues, like shortage of cost-effective and accurate smart medical sensors, unstandardised IoT system architectures, heterogeneity of connected wearable devices, multi-dimensionality of data generated and high demand for interoperability.
Hence, the issue is not only of staff shortage but also of effective work distribution amongst the available staff.
Widespread dissemination of plasmids containing multiple resistance determinants has eroded treatment options leaving few reliable antibiotics for empiric therapy, a situation exacerbated by the continuing shortage of new antibacterials effective against GNB5.
There is no shortage of innovative and effective approaches to help people achieve financial well-being.
Furthermore, there is a shortage of safe and effective treatments because these diseases present low priority markets for pharmaceutical companies [ 6].
